Alexander Roesch

11PUBLICATIONS
89CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 31, 2023
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.

Renáta Váraljai, Lisa Zimmer, Yahya Al-Matary

|May 18, 2023
HLA Class II Loss and JAK1/2 Deficiency Coevolve in Melanoma Leading to CD4 T-cell and IFNγ Cross-Resistance.

Simone Stupia, Christina Heeke, Alicia Brüggemann

|Jan 06, 2023
Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathy.

Jan-Malte Placke, Delphine Mertens, Alpaslan Tasdogan

|Oct 14, 2022
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma.

Sied Kebir, Vivien Ullrich, Pia Berger

|Jun 01, 2022
Persister state-directed transitioning and vulnerability in melanoma.

Heike Chauvistré, Batool Shannan, Sheena M Daignault-Mill

Pageof 2